Pfizer’s anti-Covid tablet is suspected to be the reason for the American president’s “rebound” in positivity, a phenomenon defined by Jean-Marc Sabatier in a latest article.
The American president, Joe Biden, 79 years outdated, examined constructive to Covid-19 on Saturday, July 30, 2022, whereas being handled with Paxlovid, the anti-Covid tablet from Pfizer. Even when he doesn’t present any signs, Joe Biden should keep in isolation for a couple of days “to guard his family members” says a White Home assertion. The president had already examined constructive on July 21 and needed to stay in isolation. Contemplating his age and his operate, Joe Biden is quadruple vaccinated. In response to his private doctor, Kevin O’Connor, “circumstances of rebound positivity can happen in individuals handled with Paxlovid.
“Vaccines facilitate an infection”
That is very exactly what Jean-Marc Sabatier* acknowledged in an article we revealed on July 20, 2022 beneath the title: “Vaccines: the third dose boosts Covid“. In that article, Jean-Marc Sabatier defined that “well being/political authorities justify vaccine boosters by arguing that rising variants or sub-variants of SARS-CoV-2 are extra deleterious/virulent on our organisms. The truth is, these new variants or sub-variants have gotten extra deleterious on our organisms, primarily due to repeated vaccine injections and an infection(s) that promote and amplify the phenomena of viral an infection facilitation, known as ADE/ERD. We’re in a vicious circle.
Already a 12 months in the past, Jean-Marc Sabatier emphasised “the existence of three forms of antibodies: neutralizers, neutrals and facilitators. Present vaccines, based mostly on the SARS-CoV-2 Spike protein, produce all three forms of antibodies. Therefore the difficulties seen after vaccination of some sufferers. Therefore additionally the worrisome 3ᵉ or 4ᵉ dose vaccination technique advocated by well being authorities.”
Joe Biden is undoubtedly a living proof.
*Jean-Marc Sabatier is Director of Analysis on the CNRS and holds a PhD in Cell Biology and Microbiology and an HDR in Biochemistry. Editor-in-Chief of the worldwide scientific journals: “Coronaviruses” and “Infectious Problems – Drug Targets”. He’s talking in his personal title.
